- Watanabe K, Yuki S, Saito K, Sato S, Sugimoto J, Ohori Y. Pharmacological studies of MCI-186, a new drug for acute stroke. Jpn Pharmacol Ther 1997;25: S1691–S1698.
- Watanabe K, Watanabe K, Hayase T. Radical scavenging mechanism of MCI-186. Jpn Phannacol Ther 1997; 25: S1699–S1707.
- Yamamoto Y, Kuwahara T, Watanabe K, Watanabe K. Antioxidant activity of 3-methy1-1-pheny1-2-pyrazoline-5-one. Redox Report 1996;2: 333–338.
- Kosaka H, Wishnok JS, Miwa M, Leaf CD, Tannenbaum SR. Nitrosation by stimulated macrophages. Inhibitors, enhancers and substrates. Carcinogenesis 1989; 10: 563–566.
- Kimura E, Yoshimine T, Iwatsuki K et al. Generation of nitric oxide and superoxide during reperfusion after focal cerebral ischemia in rats. Am J Physiol 1996;270: C748–C752.
- Ischiopoulous H, Zhu L, Beckman JS. Peroxynitrite formation from macrophage-derived nitric oxide. Arch Biochem Biophys 1992;298: 446–451.
- Olesen J, Thomsen LL, Iversen H. Nitric oxide is a key molecule in migraine and other vascular headaches. Trends Phannacol Sci 1994; 15: 149–153.
- Olesen J, Olesen II. Nitric oxide mechanisms in migraine. Pathol Biol 2000; 48: 648–657.
- Gatto EM, Riobo NA, Carreras MC et al. Overexpression of neutrophil neuronal nitric oxide synthase in Parkinson's disease. Nitric Oxide 2000; 4: 534–539.
- Beal MF. Excitotoxicity and nitric oxide in Parkinson's disease pathogenesis. Ann Neurol 1998; 44: S110–S114.
- Qureshi GA, Baig S, Bednar I, Sodersten P, Forsberg G, Siden A. Increased cerebrospinal fluid concentration of nitrite in Parkinson's disease. Neuroreport 1995; 6: 1642–1644.
- Dorheim MA, Tracey WR, Pollock JS, Grammas P. Nitric oxide synthase activity is elevated in brain microvessels in Alzheimer's disease. Biochem Biophys Res Commun 1994; 205: 659–665.
- Law A, Gauthier S, Quirion R. Say NO to Alzheimer's disease: the putative links between nitric oxide and dementia of the Alzheimer's type. Brain Res Rev 2001; 35: 73–96.
- Akaike T, Maeda H. Quantitation of nitric oxide using 2-phenyl-4,4,5,5 -tetramethylimidazoline-1 -oxy 3-oxide (PTIO). Methods Enzymol 1996;268: 211–222.
- Nishibayashi S, Asanuma M, Kohno M, Gomez-Vargas M, Ogawa N. Scavenging effects of dopamine agonists on nitric oxide radicals. J Neurochem 1996; 67: 2208–2211.
- Noda Y, Mori A, Packer L. Glidazide scavenges hydroxyl, superoxide and nitric oxide radicals: an ESR study. Res Commun Mol Pathol Pharmacol 1997; 96: 113–122.
- Asanuma M, Nishibayashi-Asanuma S, Miyazaki I, Kohno M, Ogawa N. Neuroprotective effects of non-steroidal anti-inflammatory drugs by direct scavenging of nitric oxide radicals. J Neurochem 2001;76: 1895–1904.
- Ikeda Y, Matsumoto K, Satoh K. Nitric oxide scavenging activity of Etodolac, cyclooxygenase (COX)- 2 inhibitor. J Clin Exp Med 2001;199: 471–472.
- Mitsuta K, Mizuta Y, Kohno M, Hiramatsu M, Mori A. The application of ESR spin-trapping technique to the evaluation of SOD-like activity of biological substances. Bull Chem Soc Jpn 1990; 63: 187–191.
- Akaike T, Yoshida M, Miyamoto Y et al. Antagonistic action of imidazolineoxy N-oxides against endothelium-derived relaxing factorrNO through a radical reaction. Biochemistry 1993; 32: 827–832.
- Hogg N, Singh RJ, Joseph J, Neese F, Kalyanaraman B. Reactions of nitric oxide with nitronyl nitroxide and oxygen: prediction of nitrite and nitrate formation by kinetic simulation. Free Radic Res 1995; 22: 47–56.
- Choose new content alerts to be informed about new research of interest to you
- Easy remote access to your institution's subscriptions on any device, from any location
- Save your searches and schedule alerts to send you new results
- Export your search results into a .csv file to support your research